Arcutis Biotherapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Westlake Village, CA
ARQT chart
What traders are saying about $ARQT
Latest postsArcutis Biotherapeutics, Inc. news
- Arcutis Biotherapeutics to present at Guggenhei...
Pluang ·
- Arcutis Management to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Yahoo Finance ·
- INDV Stock Price and Chart — NASDAQ:INDV
TradingView ·
- Arcutis Biotherapeutics, Inc. Estimates – NASDAQ:ARQT
TradingView ·
- Did Raised Sales Guidance Just Shift Arcutis Biotherapeutics (ARQT) Investment Narrative?
Simply Wall Street ·
- ARQT Q3'26 Earnings: revenue estimate is 142.59M USD
TradingView ·
- Arcutis Biotherapeutics, Inc. (ARQT) stock price, news, quote and history
Yahoo Finance Singapore ·
- Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
Yahoo Finance ·
- Arcutis to report Q3 2026 earnings and hold con...
Pluang ·
- Form 144 Arcutis Biotherapeutics For: 20 October By Investing.com
Investing.com India ·
- Arcutis Biotherapeutics (ARQT) Gets New Rating Uprgades from 2 Analysts; Shares Climb
Yahoo Finance ·
- Clinical Data Update Could Shape The Case For Arcutis Biotherapeutics Stock
Yahoo Finance ·
Arcutis Biotherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $376.1M | $196.5M | $59.6M | $3.7M |
| Net income | -$16.1M | -$140.0M | -$262.1M | -$311.5M |
| Diluted EPS | $-0.13 | $-1.16 | $-3.78 | $-5.66 |
| Total assets (year end) | $433.0M | $348.9M | $341.4M | $449.3M |
| Cash and equivalents (year end) | $42.9M | $71.3M | $88.4M | $53.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arcutis Biotherapeutics, Inc.
- Ticker
- ARQT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Westlake Village, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1787306
- Former names
- Arcutis, Inc.
Frequently asked questions
What exchange is Arcutis Biotherapeutics, Inc. listed on?
Arcutis Biotherapeutics, Inc. trades on the Nasdaq under the ticker symbol ARQT.
What industry is Arcutis Biotherapeutics, Inc. in?
Arcutis Biotherapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arcutis Biotherapeutics, Inc. headquartered?
Arcutis Biotherapeutics, Inc.'s business address on file with the SEC is in Westlake Village, CA.
When does Arcutis Biotherapeutics, Inc.'s fiscal year end?
Arcutis Biotherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Arcutis Biotherapeutics, Inc. report?
Arcutis Biotherapeutics, Inc. reported $376.1M in revenue for calendar year 2025, according to its SEC filings.